Skip to main content

Table 1 Baseline and procedural characteristics in relation to type of treatment of DM

From: The impact of diabetes mellitus on acute kidney injury after coronary artery bypass grafting

Variable

All cases

No-DM group

DM-oral group

p

DM-insulin group

p

(n = 4325)

(n = 3067)

(n = 706)

(n = 552)

Age, y

64.1 ± 8.4

64.2 ± 8.1

64.8 ± 7.6

0.073

62.7 ± 9.3

< 0.001

Female gender

793(18.3)

506(16.5)

148(21.0)

0.005

139(25.2)

< 0.001

BMI, kg/m2

26.7 ± 4.9

26.5 ± 4.6

27.3 ± 5.2

< 0.001

27.1 ± 5.7

0.002

eGFR(ml/min/1.73m2)

78.3 ± 18.0

80.3 ± 17.8

76.3 ± 16.3

< 0.001

69.5 ± 19.4

< 0.001

Hypertension

2047(47.3)

1414(46.1)

343(48.6)

0.234

290(52.5)

0.005

Hyperlipemia

1095(25.3)

770(25.1)

161(22.8)

0.201

164(29.7)

0.023

COPD

312(7.2)

221(7.2)

53(7.5)

0.781

38(6.9)

0.787

Peripheral vascular disease

369(8.5)

230(7.5)

71(10.1)

0.024

68(12.3)

< 0.001

Prior

 CVA

253(5.8)

160(5.2)

45(6.4)

0.221

48(8.7)

< 0.001

 MI

697(16.1)

463(15.1)

130(18.4)

0.029

104(18.8)

0.026

 PCI

739(17.1)

482(15.7)

134(19.0)

0.034

123(22.3)

< 0.001

LVEF

   

0.867

 

0.03

  > 0.50

3140(72.6)

2248(73.3)

513(72.7)

 

379(68.6)

 

 0.30–0.50

1066(24.6)

742(24.2)

173(24.5)

 

151(27.4)

 

  < 0.30

119(2.8)

77(2.5)

20(2.8)

 

22(4.0)

 

No. of vessel disease

   

0.156

 

0.02

 1 vessel

222(5.1)

181(5.9)

29(4.1)

 

12(2.2)

 

 2 vessel

473(10.9)

328(10.7)

81(11.5)

 

64(11.6)

 

 3 vessel

3630(83.9)

2558(83.4)

596(84.4)

 

476(86.2)

 

 Left main disease

1073(24.8)

721(23.5)

179(25.4)

0.299

173(31.3)

< 0.001

EuroSCOREII

2.1 ± 0.8

1.9 ± 0.7

2.4 ± 0.9

< 0.001

3.1 ± 1.1

< 0.001

Distal anastomosis

 LIMA

3954(91.4)

2828(92.2)

637(90.2)

0.083

489(88.6)

0.005

 Radial artery

151(3.5)

107(3.5)

26(3.7)

0.801

18(3.3)

0.787

On-pump

1854(42.9)

1270(41.4)

315(44.6)

0.119

269(48.7)

0.001

CPB time(min)

74.2 ± 19.5

71.5 ± 18.9

78.5 ± 20.7

< 0.001

83.5 ± 23.2

< 0.001

  1. No-DM group: non-DM; DM-oral group: DM with oral hypoglycemic agents; DM-insulin group: DM with insulin treatment, and with or without oral hypoglycemic agents. BMI body mass index, eGFR estimated glomerular filtration rate, COPD chronic obstructive pulmonary disease, CVA cerebro-vascular accident, MI myocardial infarction, PCI percutaneous coronary intervention, LVEF left ventricular ejection fraction, LIMA left internal mammary artery, CPB cardiopulmonary bypass